Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Treatment begins in first FDA-cleared Cavatak trial

Jan. 19, 2012

Phase I trial starts for Celldex Therapeutics' CDX-301

Jan. 19, 2012

Joint research agreement targets novel biofocused anticancer therapies

Jan. 19, 2012

Phase II tivantinib study in second-line hepatocellular carcinoma meets primary endpoint

Jan. 18, 2012

FDA approves new product for methotrexate poisoning due to impaired renal function

Jan. 18, 2012

Niiki Pharma completes first-in-human trial of anticancer agent

Jan. 18, 2012

Ranmark approved in Japan

Jan. 18, 2012

One-pot cascade synthesis yields modulators of centrosome integrity

Jan. 18, 2012

Researchers at Novartis present new insulin-like growth factor 1 receptor antagonists

Jan. 18, 2012

Full results published of phase III breast cancer study CLEOPATRA

Jan. 18, 2012

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026